4 Schizophrenia Clinical Trials in Riverside, RI (2026)

Q: How do I join a clinical trial in Riverside?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Riverside research site will contact you.

Recruiting Schizophrenia Studies in Riverside

NCT05184335Recruiting

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

This study is to evaluate the effect and safety of Brilaroxazine in patients with acute schizophrenia compared to the placebo short and long-term. Brilaroxazine will be given at fixed doses of 15 mg o...

Riverside, RI690 participantsReviva Pharmaceuticals

View Study Details

NCT06894212Recruiting

A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

This is a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Determine the the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants with Schizophrenia...

Riverside, RI522 participantsOtsuka Pharmaceutical Development & Commercialization, Inc.

View Study Details

NCT07363577Recruiting

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

This is a Phase 3, randomized, double blind, placebo controlled, fixed dose, study designed to evaluate the efficacy, safety, tolerability, and of LB-102 versus placebo for the treatment of adult pati...

Riverside, RI456 participantsLB Pharmaceuticals Inc.

View Study Details

NCT07105098Recruiting

NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults....

Riverside, RI284 participantsNeurocrine Biosciences

View Study Details

About Schizophrenia Clinical Trials in Riverside

Schizophrenia is a chronic brain disorder affecting approximately 2.8 million US adults, characterized by hallucinations, delusions, disorganized thinking, and cognitive difficulties. While current treatments rely primarily on first- and second-generation antipsychotics (risperidone, olanzapine, clozapine), many patients experience incomplete symptom relief or significant side effects. Clinical trials are testing novel mechanisms including muscarinic receptor agonists (like KarXT/xanomeline-trospium), trace amine-associated receptor 1 (TAAR1) agonists, glutamate modulators, and long-acting injectable formulations. Treatment-resistant schizophrenia remains a major focus area, with trials seeking patients who have not adequately responded to standard antipsychotic therapy.

There are currently 4 schizophrenia clinical trials recruiting participants in Riverside, RI. These studies are seeking a combined 1,952 participants. Research is being sponsored by Reviva Pharmaceuticals, Otsuka Pharmaceutical Development & Commercialization, Inc., LB Pharmaceuticals Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Schizophrenia Clinical Trials in Riverside — FAQ

Are there schizophrenia clinical trials in Riverside?

Yes, there are 4 schizophrenia clinical trials currently recruiting in Riverside, RI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Riverside?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Riverside research site will contact you about next steps.

Are clinical trials in Riverside free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Riverside studies also compensate for your time and travel.

What schizophrenia treatments are being tested?

The 4 active trials in Riverside are testing new therapies including novel drugs, biologics, and treatment approaches for schizophrenia.

Data updated July 13, 2026 from ClinicalTrials.gov